Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Taiwan / NCT05856474
Recruiting Observational

Management of Traumatic Pancreas Transection

NCT05856474 · tracked via the Priya Life Science Taiwan tracker
Sponsor
National Cheng-Kung University Hospital
Phase
Observational
Started
2008-01-01
Last updated
2023-05-12

Condition(s) studied

Pancreatectomy

Investigational drug(s) / intervention(s)

pancreatectomy

pancreatectomy: pancreaserving surgery, using end to side or end to end, pancreaticojejunostomy

Study summary

The goal of this observational study is to learn about the type of surgical effect on pancreas transection.

The main questions aims to answer are:

* 1\. does pancreas preserving able to decrease incidence of postoperative diabeters
* 2\. what is cause of major cause of postoperative morbidity and mortality in pancreas transection

Eligibility

Sex
ALL
Min age
1 Year
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * Diagnosed to have pancreas injury confirmed to pancreas injury by laparotomy. Exclusion Criteria: * negative pancreas injury by laparotomy

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
National Cheng Kung University Hospital Tainan Taiwan Recruiting

More National Cheng-Kung University Hospital trials in Taiwan

Precise Endoscopic Application of Nitroglycerin in Preventing Post-ERCP Pancreatitis Recruiting
Prevention of Post-sphincterotomy Bleeding Recruiting
Establishing Best Treatment Strategy for T4 Esophageal Cancer Recruiting
Non-invasive Brain Stimulation Normalizes Dopaminergic Transmission in the Frontostriatal Circuit to Alleviate Depression With Metabolic Disorders. Active, not recruiting
Comprehensive Respiratory Training Exercise Program in Obstructive Sleep Apnea Recruiting

Other trials for the same condition

Multimodal Therapy Impact on Pancreatic Cancer Survival Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05856474 on ClinicalTrials.gov ↗ ← All trials in Taiwan